Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial
Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page
- Check5 days agoChange DetectedRevision updated to v3.0.2; the Back to Top link was removed.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as updated drug information for Dolutegravir. Notably, the previous drug information for Rilpivirine has been removed.SummaryDifference1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.3%
Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.